Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
2,293,688
-
Share change
-
-215,980
-
Total reported value
-
$7,041,000
-
Price per share
-
$3.07
-
Number of holders
-
7
-
Value change
-
-$920,855
-
Number of buys
-
2
-
Number of sells
-
6
Institutional Holders of ASLAN PHARMACEUTICALS LTD - ADS (ASLN) as of Q2 2019
As of 30 Jun 2019,
ASLAN PHARMACEUTICALS LTD - ADS (ASLN) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,293,688 shares.
The largest 7 holders included
Temasek Holdings (Private) Ltd, BAILLIE GIFFORD & CO, PLATINUM INVESTMENT MANAGEMENT LTD, FNY Investment Advisers, LLC, MILLENNIUM MANAGEMENT LLC, UBS Group AG, and Tower Research Capital LLC (TRC).
This page lists
7
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.